A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Clinical trial NCT04216290 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04216290
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Urothelial Carcinoma Stage III Bladder Cancer AJCC v8

Start date: 2021-03-17
Primary completion: 2026-02-04
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.